Charles River Laboratories International Inc
(NYSE:CRL)
$
214.2
25.52 (13.53%)
Market Cap: 10.95 Bil
Enterprise Value: 13.50 Bil
PE Ratio: 25.59
PB Ratio: 2.97
GF Score: 0/100 Charles River Laboratories International Inc at Credit Suisse Healthcare Conference - Scottsdale Transcript
Nov 12, 2019 / 05:20PM GMT
Release Date Price:
$135.12
(+2.36%)
Erin Elizabeth Wilson Wright;dit Suisse AG
CrÃ;Research Division - Director & Senior Equity Research Analyst
© -
Good afternoon, or good morning, everybody. My name is Erin Wright. I cover life sciences tools and diagnostics at Crédit Suisse. We're happy to have Charles River Laboratories with us today. We have Birgit Girshick. And let me see if I get everything that you do on here, but you're EVP of Discovery and Safety Assessment, Biologics Testing Solutions and Avian Vaccine Services. Hopefully, I got it all there.
Birgit Girshick
Charles River Laboratories International, Inc. - EVP of Discovery & Safety Assessment, Biologics Testing Solutions and Avian Vaccine Services
That is correct.
Questions & Answers
Erin Elizabeth Wilson Wright;dit Suisse AG
CrÃ;Research Division - Director & Senior Equity Research Analyst
© -
So we're happy to have you and, hopefully, you'll offer us some of your expertise here. In general, I did want to give
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot